Emergency department presentations of naltrexone-accelerated detoxification

Academic Emergency Medicine

Volumn 10, Issue 8, 2003, Pages 860-866

  Armstrong, Jason ^a   Little, Mark ^a   Murray, Lindsay ^a  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

Heroin; Naltrexone; Naltrexone accelerated detoxification; Opioid detoxification; Opioid withdrawal; Opioids

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIDIARRHEAL AGENT; ANTIEMETIC AGENT; BENZODIAZEPINE DERIVATIVE; CELECOXIB; CHLORPROMAZINE; CLONIDINE; DOPAMINE RECEPTOR BLOCKING AGENT; FLUNITRAZEPAM; HALOPERIDOL; LOPERAMIDE; METOCLOPRAMIDE; MIDAZOLAM; NALOXONE; NALTREXONE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN; OCTREOTIDE; ONDANSETRON; OPIATE ANTAGONIST; QUININE SULFATE; SCOPOLAMINE BUTYL BROMIDE; SEDATIVE AGENT; SEROTONIN 3 ANTAGONIST; SOMATOSTATIN DERIVATIVE; SPASMOLYTIC AGENT; UNINDEXED DRUG;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGITATION; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONSERVATIVE TREATMENT; DIARRHEA; DROWSINESS; DRUG DETOXIFICATION; EMERGENCY WARD; ENDOTRACHEAL INTUBATION; FEMALE; GASTROINTESTINAL SYMPTOM; HOSPITALIZATION; HUMAN; INTRAVENOUS ADMINISTRATION; LENGTH OF STAY; MALE; NURSING; PATIENT CARE; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESPIRATORY DISTRESS; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; SEDATION; TACHYPNEA; UNITED STATES; VOMITING;

EID: 0041418207     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1197/aemj.10.8.860     Document Type: Article

References (23)

1. Gonzalez J, Brogden R. Naltrexone: a review of its pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence. Drugs. 1988; 35:192-213.
2. Naltrexone: Product monograph. EMIMS. online 2001.
3. Hall WD, Wodak A. Is naltrexone a cure for heroin dependence? Med J Aust. 1999; 171:9-10.
4. Kirchmayer U, Davoli M, Verster A. Naltrexone maintenance treatment for opioid dependence (Cochrane Review). Cochrane Database Syst Rev. 2000; 4:CD00133.
5. Bristow K, Meek R, Clark N. Acute opioid withdrawal in the emergency department: inadvertent naltrexone abuse? Emerg Med (Fremantle). 2001; 13:359-63.
6. Hamilton RJ, Olmedo RE, Shah S, et al. Complications of ultrarapid opioid detoxification with subcutaneous naltrexone pellets. Acad Emerg Med. 2002; 9:63-8.
7. Gerra G, Zaimovic A, Rustichelli P, et al. Rapid opiate detoxication in outpatient treatment: relationship with naltrexone compliance. J Subst Abuse Treat. 2000; 18:185-91.
8. Bell JR, Young MR, Masterman SC, Morris A, Mattick RP, Bammer G. A pilot study of naltrexone-accelerated detoxification in opioid dependence. Med J Aust. 1999; 171:26-30.
9. O'Connor PG, Carroll KM, Shi JM, Schottenfeld RS, Kosten TR, Rounsaville BJ. Three methods of opioid detoxification in a primary care setting: a randomized trial. Ann Intern Med. 1997; 127:526-30.
10. McCann MJ, Miotto K, Rawson RA, Huber A, Shoptaw S, Ling W. Outpatient non-opioid detoxification for opioid withdrawal: who is likely to benefit? Am J Addict. 1997; 6:218-23.
11. O'Connor PG, Fiellin DA. Pharmacologic treatment of heroin-dependent patients. Ann Intern Med. 2000; 133:40-54.
12. Kienbaum P, Scherbaum N, Thurauf N, Michel MC, Gastpar M, Peters J. Acute detoxification of opioid-addicted patients with naloxone during propofol or methohexital anesthesia: a comparison of withdrawal symptoms, neuroendocrine, metabolic, and cardiovascular patterns. Crit Care Med. 2000; 28:969-76.
13. Gilbert EH, Lowenstein SR, Koziol-McLain J, Barta DC, Steiner J. Chart reviews in emergency medicine research: where are the methods? Ann Emerg Med. 1996; 27:305-8.
14. De Giacomo M, Gaspari R, Stefanelli A, Barelli A, Mannelli P. Emergency therapeutical approach simulating ultrarapid opioid detoxification in methadone withdrawal precipitated by erroneous administration of naltrexone. Eur J Emerg Med. 1999; 6:153-5.
15. Miotto K, McCann MJ, Rawson RA, Frosch D, Ling W. Overdose, suicide attempts and death among a cohort of naltrexone-treated opioid addicts. Drug Alcohol Depend. 1997; 45(1-2):131-4.
16. Gaughwin MD. First, do no harm: naltrexone-accelerated detoxification. Med J Aust. 1999; 171:499.
17. Rabinowitz J, Cohen H, Tarrasch R, Kotler M. Compliance to naltrexone treatment after ultra-rapid opiate detoxification: an open label naturalistic study. Drug Alcohol Depend. 1997; 47:77-86.
18. O'Connor PG, Kosten TR. Rapid and ultrarapid opioid detoxification techniques. JAMA. 1998; 279:229-34.
19. Albanese AP, Gevirtz C, Oppenheim B, Field JM, Abels I, Eustace JC. Outcome and six month follow up of patients after ultra rapid opiate detoxification (UROD). J Addict Dis. 2000; 19:11-28.
20. Australian Medical Procedures Research Foundation. Perth Naltrexone Trial report. Perth: AMPRF, 1999.
21. Spanagel R. Is there a pharmacological basis for therapy with rapid opioid detoxification? Lancet. 1999; 354:2017-8.
22. Gooberman L. Rapid opioid detoxification. JAMA. 1998; 279:1871.
23. Therapeutic guidelines: psychotropic. Version 4, 2000.